Browse All

Current Filters

CLEAR FILTER x

TITLE

Differences in Mortality Among Medicare Beneficiaries With and Without Generalized Myasthenia Gravis

Clinical Experience With Subcutaneous Efgartigimod PH20 in Patients With Newly Diagnosed Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Healthcare Costs in Commercially Insured Pediatric Patients with Generalized Myasthenia Gravis in the United States

Factors Associated with Recurrent Clinical Events among Pediatric Generalized Myasthenia Gravis Patients in the United States

Self-reported Clinical Characteristics of a U.S. Generalized Myasthenia Gravis Population Treated With Standard of Care Therapy: Results From a Real-world Patient Survey